Article Text
PDF
Abstract
Objective Sexual dysfunction is common in patients with inflammatory bowel disease (IBD). Data on IBD disease activity and IBD patients’ desire to seek specialist advice regarding sexual dysfunction are lacking. We aimed to identify sexual healthcare needs in patients with IBD.
Design/method We conducted a cross-sectional survey of adult patients with IBD at a tertiary teaching hospital. Clinical disease activity was assessed using the Harvey-Bradshaw Index for patients with Crohn’s disease and the Patient-Simple Clinical Colitis Activity Index for patients with ulcerative colitis. Sexual health questions were derived from the validated IBD-Specific Female Sexual Dysfunction and IBD-Male Sexual Dysfunction Scales. Comparisons between those with inactive and active disease were made using Fisher’s exact test.
Results 101 respondents completed the survey, of which 53 (52%) were female and 57 (56%) had Crohn’s disease. The median age was 38 (IQR 28–52). 34 respondents (34%) had active disease. Respondents with active Crohn’s disease trended towards having more significant sexual dysfunction than those in remission for all domains on the sexual dysfunction scale. 74% reported interest in accessing specialist advice regarding their sexual function while 20% have attempted to seek this advice. 36% would wish to be contacted by the IBD team if a sexual health service became available.
Conclusions Negative impacts on sexual function were common in our cohort, particularly in the presence of active disease. Most patients with IBD are interested in obtaining advice regarding their sexual function. This is an unmet need among IBD services.
- INFLAMMATORY BOWEL DISEASE
- ULCERATIVE COLITIS
- CROHN'S DISEASE
- QUALITY OF LIFE
Data availability statement
Data are available on reasonable request.
Statistics from Altmetric.com
Data availability statement
Data are available on reasonable request.
Footnotes
X @AlexElford3
ATE and WB contributed equally.
Contributors ATE, RP, AHA-A and BC contributed to the design of the study. ATE, JM and BC designed the REDCAP. JM, AD and VK emailed all patients. ATE, WB, AD, VK, JM, AHA-A, JS and BC were involved in recruitment. ATE and WB drafted the first version of the manuscript. All authors critically reviewed the manuscript for important intellectual content. All authors approved the final version of the manuscript. BC is the guarantor.
Funding ATE and AHA-A are supported by the Australian Commonwealth government via a Research Training Program Scholarship.
Competing interests ATE and AHA-A are supported by the Australian Commonwealth government via a Research Training Program Scholarship. AHA-A is also supported by the Crohn’s Colitis Australia PhD Scholarship, Avant Doctors-in-Training Scholarship and the Gastroenterology Society of Australia Celltrion IBD Fellowship. RP is supported by a National Health and Medical Research Council Scholarship, a Crohn’s Colitis Australia PhD Scholarship, and two research grants from Ferring Pharmaceuticals. JS received speaker fees for Takeda and Abbvie, BMS and Falk Pharma and has a non-restricted grant from Tillots. BC has received speaking fees from Abbvie, Janssen, Pfizer, Takeda and Ferring; research grants from Janssen and Ferring Pharmaceuticals and served on the advisory board of Gilead and Novartis.
Provenance and peer review Not commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.